Menu

Boehringer Ingelheim will require all 340B covered entities to submit pharmacy and medical claims data on all dispenses, including at in-house pharmacies, beginning July 6.

BI 12th Drugmaker to Require In-House Claims Data

June 23, 2026 Shannon Young, Managing Editor 340B Report Views

German drugmaker Boehringer Ingelheim (BI) will require all 340B covered entities to submit pharmacy and medical claims data on all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

PDAB Advocates Push Vetoed Virginia Model, but 340B Concerns Remain

Model N Acquires Kalderos, Looks to Expand its 340B Capabilities